Published: Guidance, quality standards and advice
Showing 21 to 24 of 24
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Cabozantinib for untreated advanced renal cell carcinoma | TA542 | ||
| Tofacitinib for treating active psoriatic arthritis after inadequate response to DMARDs | TA543 | ||
| myAIRVO2 for the treatment of chronic obstructive pulmonary disease | MIB161 | ||
| E‑vita open plus for treating complex aneurysms and dissections of the thoracic aorta | HTG326 |